Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Grin'kina, Natalia M ^a,b   Karnabi, Eddy E ^a,b   Damania, Dushyant ^a   Wadgaonkar, Sunil ^b   Muslimov, Ilham A ^a   Wadgaonkar, Raj ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; SPHINGOSINE KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVATION; FEMALE; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; UPREGULATION; WHITE MATTER; WILD TYPE;

BACTERIA (MICROORGANISMS); MUS;

EID: 84861204232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036475     Document Type: Article

References (68)

1. Carpenter S, O'Neill LA, (2007) How important are Toll-like receptors for antimicrobial responses? Cell Microbiol 9: 1891-1901.
2. Abreu MT, Arditi M, (2004) Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 144: 421-429.
3. Triantafilou M, Triantafilou K, (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23: 301-304.
4. Munoz L, Ammit AJ, (2009) Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology.
5. Yong VW, Rivest S, (2009) Taking advantage of the systemic immune system to cure brain diseases. Neuron 64: 55-60.
6. Pfeiffer RF, (2009) Neuroinflammation and Parkinson disease: the silent battleground. Neurology 73: 1434-1435.
7. Pang Y, Cai Z, Rhodes PG, (2003) Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 140: 205-214.
8. Frank-Cannon TC, Alto LT, McAlpine FE, Tansey MG, (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4: 47.
9. Spain RI, Cameron MH, Bourdette D, (2009) Recent developments in multiple sclerosis therapeutics. BMC Med 7: 74.
10. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED, (2000) Pathophysiology of septic encephalopathy: a review. Crit Care Med 28: 3019-3024.
11. Caroff M, Karibian D, Cavaillon JM, Haeffner-Cavaillon N, (2002) Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 4: 915-926.
12. Leon CG, Tory R, Jia J, Sivak O, Wasan KM, (2008) Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 25: 1751-1761.
13. Zhou H, Andonegui G, Wong CH, Kubes P, (2009) Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J Immunol 183: 5244-5250.
14. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752.
15. Kono M, Allende ML, Proia RL, (2008) Sphingosine-1-phosphate regulation of mammalian development. Biochim Biophys Acta 1781: 435-441.
16. Takabe K, Paugh SW, Milstien S, Spiegel S, (2008) "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60: 181-195.
17. Okada T, Kajimoto T, Jahangeer S, Nakamura S, (2009) Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system. Cell Signal 21: 7-13.
18. Kimura A, Ohmori T, Kashiwakura Y, Ohkawa R, Madoiwa S, et al. (2008) Antagonism of sphingosine 1-phosphate receptor-2 enhances migration of neural progenitor cells toward an area of brain. Stroke 39: 3411-3417.
19. Ohama T, Okada M, Murata T, Brautigan DL, Hori M, et al. (2008) Sphingosine-1-phosphate enhances IL-1{beta}-induced COX-2 expression in mouse intestinal subepithelial myofibroblasts. Am J Physiol Gastrointest Liver Physiol 295: G766-775.
20. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S, (2006) Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026.
21. Don AS, Rosen H, (2009) A lipid binding domain in sphingosine kinase 2. Biochem Biophys Res Commun 380: 87-92.
22. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, et al. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275: 19513-19520.
23. Wadgaonkar R, Patel V, Grinkina N, Romano C, Liu J, et al. (2009) Differential regulation of sphingosine kinases 1 and 2 in lung injury. Am J Physiol Lung Cell Mol Physiol 296: L603-613.
24. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, et al. (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108: 689-701.
25. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, et al. (2004) Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169: 1245-1251.
26. McVerry BJ, Garcia JG, (2004) Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem 92: 1075-1085.
27. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, et al. (2004) Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 170: 987-993.
28. Lai WQ, Irwan AW, Goh HH, Howe HS, Yu DT, et al. (2008) Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 181: 8010-8017.
29. Melendez AJ, (2008) Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim Biophys Acta 1784: 66-75.
30. Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, et al. (2009) A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J 23: 143-152.
31. Wu W, Mosteller RD, Broek D, (2004) Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol Cell Biol 24: 7359-7369.
32. Puneet P, Yap CT, Wong L, Lam Y, Koh DR, et al. (2010) SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 328: 1290-1294.
33. Nayak D, Huo Y, Kwang WX, Pushparaj PN, Kumar SD, et al. (2010) Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166: 132-144.
34. Cai Z, Pang Y, Lin S, Rhodes PG, (2003) Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975: 37-47.
35. Karnabi E, Qu Y, Mancarella S, Yue Y, Wadgaonkar R, et al. (2009) Silencing of Cav1.2 gene in neonatal cardiomyocytes by lentiviral delivered shRNA. Biochem Biophys Res Commun 384: 409-414.
36. Arican N, Kaya M, Kalayci R, Uzun H, Ahishali B, et al. (2006) Effects of lipopolysaccharide on blood-brain barrier permeability during pentylenetetrazole-induced epileptic seizures in rats. Life Sci 79: 1-7.
37. Banks WA, Erickson MA, (2010) The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 37: 26-32.
38. O'Sullivan M, (2008) Leukoaraiosis. Pract Neurol 8: 26-38.
39. Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, et al. (2009) Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 40: 3466-3471.
40. Brown WR, Moody DM, Thore CR, Challa VR, (2000) Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann N Y Acad Sci 903: 39-45.
41. Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, et al. (2008) Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 103: 1164-1172.
42. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, et al. (2004) Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 75: 441-447.
43. Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K, (1989) Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol 79: 129-136.
44. Brahmachari S, Fung YK, Pahan K, (2006) Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 26: 4930-4939.
45. Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, et al. (2008) Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation 5: 38.
46. Pang Y, Cai Z, Rhodes PG, (2000) Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia. J Neurosci Res 62: 510-520.
47. Vlasenko LP, Melendez AJ, (2005) A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo. J Immunol 174: 6456-6461.
48. Lai WQ, Irwan AW, Goh HH, Melendez AJ, McInnes IB, et al. (2009) Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J Immunol 183: 2097-2103.
49. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, et al. (2005) Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25: 11113-11121.
50. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, et al. (2002) Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22: 455-463.
51. Li J, Ramenaden ER, Peng J, Koito H, Volpe JJ, et al. (2008) Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci 28: 5321-5330.
52. Xiao Y, Li H, Zhang J, Volk A, Zhang S, et al. (2011) TNF-alpha/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations. Blood 118: 6057-6067.
53. Berdyshev EV, Gorshkova I, Usatyuk P, Kalari S, Zhao Y, et al. (2011) Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS One 6: e16571.
54. Zhao Y, Kalari SK, Usatyuk PV, Gorshkova I, He D, et al. (2007) Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 282: 14165-14177.
55. Skoura A, Hla T, (2009) Lysophospholipid receptors in vertebrate development, physiology, and pathology. J Lipid Res 50 Suppl pp. S293-298.
56. Zhao YD, Ohkawara H, Rehman J, Wary KK, Vogel SM, et al. (2009) Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. Circ Res 105: 696-704, 698 p following 704.
57. Ahmed SH, He YY, Nassief A, Xu J, Xu XM, et al. (2000) Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 31: 193-199.
58. Olson JK, Miller SD, (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173: 3916-3924.
59. Sugama S, Takenouchi T, Fujita M, Conti B, Hashimoto M, (2009) Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 207: 24-31.
60. Ji KA, Yang MS, Jeong HK, Min KJ, Kang SH, et al. (2007) Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain. Glia 55: 1577-1588.
61. Saura J, (2007) Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 4: 26.
62. Eklind S, Hagberg H, Wang X, Savman K, Leverin AL, et al. (2006) Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr Res 60: 161-168.
63. Maceyka M, Milstien S, Spiegel S, (2005) Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. Prostaglandins Other Lipid Mediat 77: 15-22.
64. Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, et al. (2010) Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am J Pathol 176: 2682-2694.
65. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, et al. (1998) Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 273: 23722-23728.
66. Michaud J, Kohno M, Proia RL, Hla T, (2006) Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett 580: 4607-4612.
67. Bryan L, Kordula T, Spiegel S, Milstien S, (2008) Regulation and functions of sphingosine kinases in the brain. Biochim Biophys Acta 1781: 459-466.
68. Kihara A, Anada Y, Igarashi Y, (2006) Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification, and oligomerization. J Biol Chem 281: 4532-4539.